Revenue (Quarterly) Chart

View Revenue (Quarterly) for EGLNF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 2012. Start Trial.
Date Value
June 30, 2026 83.52M
March 31, 2026 84.11M
December 31, 2025 86.22M
September 30, 2025 85.01M
June 30, 2025 87.28M
March 31, 2025 78.31M
December 31, 2024 81.01M
September 30, 2024 77.89M
June 30, 2024 80.18M
March 31, 2024 75.12M
December 31, 2023 83.85M
September 30, 2023 78.00M
June 30, 2023 87.02M
March 31, 2023 81.85M
December 31, 2022 85.25M
September 30, 2022 77.73M
June 30, 2022 82.89M
March 31, 2022 93.04M
December 31, 2021 97.86M
September 30, 2021 101.54M
June 30, 2021 40.00M
March 31, 2021 36.07M
September 30, 2020 35.62M
June 30, 2020 32.12M
March 31, 2020 26.27M
Date Value
December 31, 2019 29.61M
September 30, 2019 32.81M
June 30, 2019 32.08M
March 31, 2019 31.66M
December 31, 2018 30.43M
September 30, 2018 36.24M
June 30, 2018 36.25M
March 31, 2018 34.44M
December 31, 2017 30.56M
September 30, 2017 32.94M
June 30, 2017 32.42M
March 31, 2017 29.55M
December 31, 2016 29.89M
September 30, 2016 28.54M
June 30, 2016 27.35M
March 31, 2016 25.10M
December 31, 2015 19.27M
September 30, 2015 14.73M
June 30, 2015 13.03M
March 31, 2015 11.58M
December 31, 2014 10.15M
September 30, 2014 8.291M
June 30, 2014 7.161M
March 31, 2014 7.322M
December 31, 2013 6.980M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Kao Corp. 2.879B
Kosé Holdings Corp. 543.76M
Milbon Co., Ltd. 90.76M
Rohto Pharmaceutical Co., Ltd. 574.97M
Mandom Corp. 116.45M